Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
CALL
McCormick & Company Non-Voting
MKC
$14.8B
| $3.01M | ﹤0.01% |
+40,000
| New | +$2.7M |
|
2102
Cemex
CX
$15.8B
| $3.01M | ﹤0.01% |
648,123
-3,268,700
| -83% | -$16.4M |
|
|
CAMP
2103
DELISTED
CalAmp Corp.
CAMP
| $3M | ﹤0.01% |
10,379
+6,542
| +170% | +$2.07M |
|
|
AXIA
2104
DELISTED
AXIA Energia
AXIA
| $3M | ﹤0.01% |
404,755
+87,784
| +28% | +$640K |
|
|
LVOXU
2105
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
| $3M | ﹤0.01% |
+300,000
| New | +$3M |
|
|
EIGR
2106
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.97M | ﹤0.01% |
7,081
+6,245
| +747% | +$2.51M |
|
|
TBRG
2107
CALL
DELISTED
TruBridge
TBRG
| $2.97M | ﹤0.01% |
+100,000
| New | +$2.89M |
|
2108
argenx
ARGX
$65.5B
| $2.96M | ﹤0.01% |
23,734
-19,479
| -45% | -$2.29M |
|
|
ATTU
2109
DELISTED
Attunity Ltd
ATTU
| $2.96M | ﹤0.01% |
126,285
-68,444
| -35% | -$1.53M |
|
2110
CALL
Sarepta Therapeutics
SRPT
$2.06B
| $2.96M | ﹤0.01% |
24,800
-225,200
| -90% | -$29M |
|
|
KNL
2111
DELISTED
Knoll, Inc.
KNL
| $2.96M | ﹤0.01% |
156,262
-177,074
| -53% | -$3.51M |
|
2112
Repligen
RGEN
$10.2B
| $2.95M | ﹤0.01% |
50,006
-158,970
| -76% | -$9.14M |
|
2113
Matthews International
MATW
$673M
| $2.95M | ﹤0.01% |
79,858
-25,773
| -24% | -$1.05M |
|
|
CTLT
2114
DELISTED
CATALENT, INC.
CTLT
| $2.95M | ﹤0.01% |
72,689
-345,196
| -83% | -$13.5M |
|
2115
Ciena
CIEN
$57.2B
| $2.95M | ﹤0.01% |
78,940
-111,902
| -59% | -$4.35M |
|
|
SCWX
2116
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $2.95M | ﹤0.01% |
160,105
+98,375
| +159% | +$1.92M |
|
|
PSDO
2117
DELISTED
Presidio, Inc. Common Stock
PSDO
| $2.95M | ﹤0.01% |
+199,028
| New | +$3.04M |
|
|
CHAP
2118
DELISTED
Chaparral Energy, Inc.
CHAP
| $2.94M | ﹤0.01% |
514,853
+485,871
| +1,676% | +$3.22M |
|
2119
Krystal Biotech
KRYS
$10.6B
| $2.93M | ﹤0.01% |
+89,155
| New | +$2.1M |
|
|
SNCR
2120
DELISTED
Synchronoss Technologies
SNCR
| $2.92M | ﹤0.01% |
53,437
+37,570
| +237% | +$2.44M |
|
2121
PUT
Main Street Capital
MAIN
$5.46B
| $2.92M | ﹤0.01% |
+78,500
| New | +$2.92M |
|
|
DESP
2122
DELISTED
Despegar.com
DESP
| $2.92M | ﹤0.01% |
195,861
+108,746
| +125% | +$1.72M |
|
2123
Fox Class B
FOX
$26.2B
| $2.92M | ﹤0.01% |
+81,266
| New | +$3.1M |
|
2124
PUT
O'Reilly Automotive
ORLY
$72.4B
| $2.91M | ﹤0.01% |
112,500
-75,000
| -40% | -$1.81M |
|
2125
iShares Russell 1000 ETF
IWB
$48.9B
| $2.91M | ﹤0.01% |
18,484
-13,263
| -42% | -$2.01M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.